首页> 外文期刊>Antiviral Research >Phosphonoamidate prodrugs of C5-substituted pyrimidine acyclic nucleosides for antiviral therapy
【24h】

Phosphonoamidate prodrugs of C5-substituted pyrimidine acyclic nucleosides for antiviral therapy

机译:C5取代的嘧啶非纤维核苷的磷酸氨基甲酰嵌段前药进行抗病毒治疗

获取原文
获取原文并翻译 | 示例
           

摘要

Acyclic nucleoside phosphonates (ANPs) are nowadays one of the key drugs in the treatment of DNA virus and retrovirus infections. In this work, we report the synthesis and antiviral evaluation of phosphonoamidate and diamidates prodrugs of C5-pyrimidine acyclic nucleosides derivatives functionalized with but-2-enyl- chain. In the phosphonoamidate series, the most active compound 15, showed sub-micromolar activity against varicella zoster virus (VZV) (EC50 = 0.09-0.5 mu M) and mu M activity against human cytomegalovirus (HCMV) and herpes simplex virus (HSV). Separation of single diastereoisomers for compound 14, showed that 14b had better anti-herpesvirus activity and no cytotoxicity compared to the diastereoisomeric mixture 14. Very interestingly, phosphonodiamidate 21 showed anti-herpesvirus activity with excellent activity against wild type and thymidine kinase-deficient (TIC) VZV strains (EC50 = 0.47 and 0.2 mu M, respectively) and HCMV (EC50 = 3.5-7.2 mu M) without any cytotoxicity (CC50 > 100). (C) 2017 Published by Elsevier B.V.
机译:如今,无环核苷膦酸盐(ANP)是治疗DNA病毒和逆转录病毒感染的关键药物之一。在这项工作中,我们报告了用除-2-烯基官能化的C5-嘧啶的环酰基核苷衍生物的膦酰胺的合成和抗病毒评价和羟基胺衍生物。在膦酰胺族序列中,最活跃的化合物15显示针对种子菌扎带病毒(VZV)(EC50 =0.09-0.5μm)的亚微摩尔活性(EC50 =0.09-0.5μm)和uM m活性对人巨细胞病毒(HCMV)和单纯疱疹病毒(HSV)进行μM活性。用于化合物14的单一非对映异构体的分离,表明,与非对映异构混合物14相比,14b具有更好的抗疱疹病毒活性,并且没有细胞毒性。非常有趣的是,膦二亚胺21显示抗疱疹病毒活性,具有优异的野生型和胸苷激酶缺陷的活性(TIC )VZV菌株(EC50 = 0.47和0.2μm,分别)和HCMV(EC50 =3.5-7.2μm)而没有任何细胞毒性(CC50> 100)。 (c)2017年由Elsevier B.V发布。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号